These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17277077)

  • 21. Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1.
    Zhao B; Marciniuk K; Gibbs E; Yousefi M; Napper S; Cashman NR
    Vaccine; 2019 Aug; 37(35):4920-4927. PubMed ID: 31324499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Future perspectives of immunotherapy against ALS].
    Urushitani M
    Rinsho Shinkeigaku; 2009 Nov; 49(11):818-20. PubMed ID: 20030219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis.
    McAllum EJ; Lim NK; Hickey JL; Paterson BM; Donnelly PS; Li QX; Liddell JR; Barnham KJ; White AR; Crouch PJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):586-90. PubMed ID: 23952668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases.
    Ayers JI; Xu G; Pletnikova O; Troncoso JC; Hart PJ; Borchelt DR
    Acta Neuropathol Commun; 2014 May; 2():55. PubMed ID: 24887207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canine degenerative myelopathy.
    Coates JR; Wininger FA
    Vet Clin North Am Small Anim Pract; 2010 Sep; 40(5):929-50. PubMed ID: 20732599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment with lecithinized superoxide dismutase in amyotrophic lateral sclerosis].
    Kinoshita M; Ikeda K
    No To Shinkei; 1998 Jul; 50(7):615-24. PubMed ID: 9739519
    [No Abstract]   [Full Text] [Related]  

  • 27. Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis).
    Ende N; Weinstein F; Chen R; Ende M
    Life Sci; 2000 May; 67(1):53-9. PubMed ID: 10896029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of human monoclonal antibodies specific for human SOD1 recognizing distinct epitopes and forms of SOD1.
    Broering TJ; Wang H; Boatright NK; Wang Y; Baptista K; Shayan G; Garrity KA; Kayatekin C; Bosco DA; Matthews CR; Ambrosino DM; Xu Z; Babcock GJ
    PLoS One; 2013; 8(4):e61210. PubMed ID: 23613814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibody therapy targeting ALS-linked misfolded protein].
    Urushitani M
    Rinsho Shinkeigaku; 2011 Nov; 51(11):1162-4. PubMed ID: 22277520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnesium supplementation does not delay disease onset or increase survival in a mouse model of familial ALS.
    Pamphlett R; Todd E; Vink R; McQuilty R; Cheema SS
    J Neurol Sci; 2003 Dec; 216(1):95-8. PubMed ID: 14607308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic gene silencing delivered by a chemically modified small interfering RNA against mutant SOD1 slows amyotrophic lateral sclerosis progression.
    Wang H; Ghosh A; Baigude H; Yang CS; Qiu L; Xia X; Zhou H; Rana TM; Xu Z
    J Biol Chem; 2008 Jun; 283(23):15845-52. PubMed ID: 18367449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunotherapy Against Misfolded Proteins in ALS].
    Urushitani M; Tamaki Y; Hikiami R; Minamiyama S
    Brain Nerve; 2019 Nov; 71(11):1289-1301. PubMed ID: 31722315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosis.
    Chen T; Benmohamed R; Arvanites AC; Ralay Ranaivo H; Morimoto RI; Ferrante RJ; Watterson DM; Kirsch DR; Silverman RB
    Bioorg Med Chem; 2011 Jan; 19(1):613-22. PubMed ID: 21095130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-superoxide dismutase antibodies are associated with survival in patients with sporadic amyotrophic lateral sclerosis.
    van Blitterswijk M; Gulati S; Smoot E; Jaffa M; Maher N; Hyman BT; Ivinson AJ; Scherzer CR; Schoenfeld DA; Cudkowicz ME; Brown RH; Bosco DA
    Amyotroph Lateral Scler; 2011 Nov; 12(6):430-8. PubMed ID: 22023190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary restriction but not rapamycin extends disease onset and survival of the H46R/H48Q mouse model of ALS.
    Bhattacharya A; Bokov A; Muller FL; Jernigan AL; Maslin K; Diaz V; Richardson A; Van Remmen H
    Neurobiol Aging; 2012 Aug; 33(8):1829-32. PubMed ID: 21763036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormally high levels of SOD1 mRNA in a patient with amyotrophic lateral sclerosis.
    Conforti FL; Magariello A; Mazzei R; Sprovieri T; Patitucci A; Crescibene L; Bastone L; Gabriele A; Scornaienchi M; Ferraro T; Muglia M; Quattrone A
    Muscle Nerve; 2004 Apr; 29(4):610-1. PubMed ID: 15052629
    [No Abstract]   [Full Text] [Related]  

  • 37. Intrathecal administration of recombinant human superoxide dismutase 1 in amyotrophic lateral sclerosis: a preliminary safety and pharmacokinetic study.
    Cudkowicz ME; Warren L; Francis JW; Lloyd KJ; Friedlander RM; Borges LF; Kassem N; Munsat TL; Brown RH
    Neurology; 1997 Jul; 49(1):213-22. PubMed ID: 9222193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ALSUntangled No. 9: Blue-green algae (Spirulina) as a treatment for ALS.
    ALSUntangled Group
    Amyotroph Lateral Scler; 2011 Mar; 12(2):153-5. PubMed ID: 21323493
    [No Abstract]   [Full Text] [Related]  

  • 39. Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.
    Kost OA; Beznos OV; Davydova NG; Manickam DS; Nikolskaya II; Guller AE; Binevski PV; Chesnokova NB; Shekhter AB; Klyachko NL; Kabanov AV
    Oxid Med Cell Longev; 2015; 2015():5194239. PubMed ID: 26697135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter.
    Trotti D; Rolfs A; Danbolt NC; Brown RH; Hediger MA
    Nat Neurosci; 1999 Sep; 2(9):848. PubMed ID: 10461226
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.